Lisa Swanson, MD

Articles

Closing Thoughts with Patient Cases: Disease Control With Modern Therapies

April 02, 2025

A panelist discusses how contemporary therapeutic approaches enable successful management of atopic dermatitis through examination of real-world patient cases that demonstrate effective disease control strategies using the latest treatment options.

Collaborating for Better Atopic Dermatitis (AD) Care: How Primary Care and Dermatology Can Work Together

April 02, 2025

A panelist discusses how effective coordination between primary care providers and dermatologists creates a complementary care model that optimizes atopic dermatitis management through shared decision-making, clear communication pathways, and defined roles for each specialty.

Factors that Impact Therapy Decisions for Atopic Dermatitis (AD)

April 02, 2025

A panelist discusses how treatment selection for atopic dermatitis is influenced by multiple considerations including disease severity, patient age, affected body regions, comorbidities, previous treatment responses, and patient preferences.

Other Topical Options to Treat Atopic Dermatitis (AD): Topical JAK Inhibitors and AhR Agonists

April 02, 2025

A panelist discusses how topical JAK inhibitors and AhR agonists represent emerging therapeutic approaches for atopic dermatitis that target specific inflammatory pathways to provide effective symptom relief with distinct mechanisms of action.

Atopic Dermatitis (AD) Across Ages: Identifying and Treating Flares in Children and Adults

April 02, 2025

A panelist discusses how healthcare providers can effectively identify and manage atopic dermatitis flares across different age groups, highlighting the unique challenges and treatment approaches for both pediatric and adult populations.